Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antigen peptide related to lung cancer driver gene mutation and application thereof

A technology of antigenic peptides and lung cancer, applied in the field of biomedicine, can solve the problems of failure to form effects, superior therapeutic agents, etc., and achieve good clinical transformation and disease prevention prospects

Active Publication Date: 2021-11-19
深圳市新靶向生物科技有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, because technology requires multidisciplinary, high-tech, and multi-platform collaborative research, antigenic peptides related to lung cancer driver gene mutations have not been systematically discovered and a relatively complete peptide library has not been established. therapeutic agent

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antigen peptide related to lung cancer driver gene mutation and application thereof
  • Antigen peptide related to lung cancer driver gene mutation and application thereof
  • Antigen peptide related to lung cancer driver gene mutation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] Below, in conjunction with accompanying drawing and specific embodiment, the present invention is described further:

[0021] Antigen peptides related to lung cancer driver gene mutations used in the examples are shown in Table 1:

[0022] Table 1 Antigenic peptide sequences associated with lung cancer driver gene mutations

[0023]

[0024] The operation for the establishment of antigen peptide-specific CTL clones related to lung cancer driver gene mutations is as follows:

[0025] 10 from the same healthy donor 5 CD8 + T cells loaded with 10 antigenic peptides associated with lung cancer driver mutations 4 Mo-DCs were stimulated twice at intervals of 1 week, and then passed autologous 10 5 Mitomycin C-treated PBMCs loaded with antigenic peptides associated with lung cancer driver gene mutations were stimulated once and screened by standard cytotoxicity assays.

[0026] T2 cells were loaded with 5uM antigen peptides related to lung cancer driver gene mutations ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses antigen peptides related to lung cancer driver gene mutation. The sequences of the antigen peptides are SEQ ID NO.5, SEQ ID NO.9 and SEQ ID NO.24; according to the application of the antigen peptide, the antigen peptide is used for inducing generation of specific cytotoxic T cell clone; the antigen peptide has high affinity with MHC I molecules on DC cells, can effectively stimulate and induce generation of specific cytotoxic T lymphocytes, can be used for immune clearance of tumor cells with lung cancer related driver gene mutation, and has good treatment potential.

Description

[0001] This application is a divisional application with application number 202110594210.8, application date of May 28, 2021, and the title of the invention "an antigenic peptide related to lung cancer driver gene mutation and its application". technical field [0002] The invention relates to an antigenic peptide related to lung cancer driving gene mutation and application thereof, belonging to the technical field of biomedicine. Background technique [0003] Lung cancer is one of the malignant tumors with the fastest increasing morbidity and mortality and the greatest threat to the health and life of the population. In the past 50 years, many countries have reported that the morbidity and mortality of lung cancer have increased significantly. The incidence and mortality of lung cancer in men rank first among all malignant tumors, and the incidence and mortality of lung cancer occupy the second place in women. Chemotherapy is the main treatment for lung cancer, and more tha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/47C07K14/71C12N5/0783A61K39/00A61P35/00
CPCC07K14/4748C07K14/71C12N5/0638A61K39/001104A61K39/001102A61P35/00
Inventor 郝冰娜李许峰蔡睿赵环罗夫辛克纳吉张积仁
Owner 深圳市新靶向生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com